Joint Formulary & PAD

Dinoprostone - Patent ductus arteriosus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dinoprostone
Indication :
Patent ductus arteriosus
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

04 Sep 24 - ASPH DTC

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Dinoprostone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Patent ductus arteriosus.

  • No records returned.